Overview
This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of patients' clinical characteristics, it will achieve the registration, management, follow-up, and analysis of patients with Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR).
Eligibility
Inclusion Criteria:
- Age ≥ 18 years;
- Patients meeting the diagnostic criteria for Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR);
- Patients fully informed about the trial procedures who provide written informed consent.
Exclusion Criteria:
- Patients presenting with any of the following:
- Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy \<12 months;
- Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;
- Variant angina (Prinzmetal's angina);
- Coronary artery dissection;
- Thrombophilia;
- Stent underexpansion.
- Thrombophilia;
- Coronary artery dissection;
- Variant angina (Prinzmetal's angina);
- Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;
- Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy \<12 months;
- Presence of psychiatric disorders;
- Known inability to complete expected study follow-up for any reason;
- Patients deemed ineligible for enrollment by the investigator.


